Table 3.

Frequency (%) of Individual Marker Expression on B-LIN and T-LIN ALL

Marker B-LIN (n = 206) T-LIN (n = 44)
CD1+ 0%  63%  
CD2+ 6%  70%  
CD3+ 0%  41% 
CD4+ <1%  61%  
CD5+ 1%  84%  
CD7+ <1%  93% 
CD8+ 0%  55%  
CD10+ 72%  16%  
CD11c+ 1%  2% 
CD13+ 32%  25%  
CD19+ 98%  0%  
CD20+ 33%  0% 
CD22+ 87%  6%  
CD33+ 3%  2%  
CD34+ 81%  27% 
CD38+ 84%  78%  
HLA DR 96%  9%  
κ+ 1%  0% 
λ+ 1.5%  0%  
IgD+ or IgM+ 0%3-150 0%3-150 
Marker B-LIN (n = 206) T-LIN (n = 44)
CD1+ 0%  63%  
CD2+ 6%  70%  
CD3+ 0%  41% 
CD4+ <1%  61%  
CD5+ 1%  84%  
CD7+ <1%  93% 
CD8+ 0%  55%  
CD10+ 72%  16%  
CD11c+ 1%  2% 
CD13+ 32%  25%  
CD19+ 98%  0%  
CD20+ 33%  0% 
CD22+ 87%  6%  
CD33+ 3%  2%  
CD34+ 81%  27% 
CD38+ 84%  78%  
HLA DR 96%  9%  
κ+ 1%  0% 
λ+ 1.5%  0%  
IgD+ or IgM+ 0%3-150 0%3-150 

Four patients were B-LIN based on CD19 dim expression; 1 patient was not evaluable for CD19 but expressed CD20 and was thereby classified as B-LIN.

F3-150

Surface IgD or IgM expression was found on 0 of 103 B-LIN and 0 of 18 T-LIN adult ALL cases evaluated.